List of Excipients in API nepafenac
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing nepafenac
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Alcon Laboratories Inc | NEVANAC | nepafenac | 0065-0002 | BENZALKONIUM CHLORIDE | 2025-12-02 |
Alcon Laboratories Inc | NEVANAC | nepafenac | 0065-0002 | CARBOMER HOMOPOLYMER TYPE B | 2025-12-02 |
Alcon Laboratories Inc | NEVANAC | nepafenac | 0065-0002 | EDETATE DISODIUM | 2025-12-02 |
Alcon Laboratories Inc | NEVANAC | nepafenac | 0065-0002 | HYDROCHLORIC ACID | 2025-12-02 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for nepafenac
Excipient focus: BENZALKONIUM CHLORIDE
nepafenac drug variants containing BENZALKONIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing BENZALKONIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
nepafenac drug variants containing BORIC ACID
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Harrow Eye LLC | nepafenac | 82667-400 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing BORIC ACID
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
Physicians Total Care Inc | nepafenac | 54868-6302 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
nepafenac drug variants containing CARBOMER HOMOPOLYMER TYPE B
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
nepafenac drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Harrow Eye LLC | nepafenac | 82667-400 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
Physicians Total Care Inc | nepafenac | 54868-6302 |
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
nepafenac drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GUAR GUM
nepafenac drug variants containing GUAR GUM
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Harrow Eye LLC | nepafenac | 82667-400 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing GUAR GUM
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
Physicians Total Care Inc | nepafenac | 54868-6302 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
nepafenac drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
nepafenac drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
Physicians Total Care Inc | nepafenac | 54868-6302 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Harrow Eye LLC | nepafenac | 82667-400 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
nepafenac drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Harrow Eye LLC | nepafenac | 82667-400 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
Physicians Total Care Inc | nepafenac | 54868-6302 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
nepafenac drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
nepafenac drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TYLOXAPOL
nepafenac drug variants containing TYLOXAPOL
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
Physicians Total Care Inc | nepafenac | 54868-6302 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing TYLOXAPOL
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Harrow Eye LLC | nepafenac | 82667-400 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
nepafenac drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Alcon Laboratories Inc | nepafenac | 0065-0002 |
Alcon Laboratories Inc | nepafenac | 0065-1750 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0743 |
Novartis Pharmaceuticals Corporation | nepafenac | 0078-0778 |
>Company | >Ingredient | >NDC |
nepafenac drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.